Emcure Pharma IPO Details ( Emcure Pharmaceuticals Limited IPO Review )
(3 July 2024 – 5 July 2024)
Founded in 1981, Emcure Pharmaceuticals Limited is an Indian company that develops, manufactures, and markets a wide range of pharmaceutical products globally, covering several major therapeutic areas.
Market Position
As of September 2023, Emcure Pharmaceuticals is ranked 13th in domestic sales among Indian pharmaceutical companies and holds the 4th largest market share in its covered markets. It leads in the gynaecology and HIV antiviral therapeutic areas for the same period.
Revenue and Growth
In the first half of 2023 and the full Financial Year 2023, sales in India accounted for 50.84% and 53.16% of Emcure’s total revenue, respectively. From September 2019 to September 2023, the company’s domestic sales grew at a compound annual growth rate (CAGR) of 10.80%, surpassing the overall Indian pharmaceutical market growth.
Research and Development
By September 30, 2023, Emcure employed 552 scientists and operated five research facilities in India. The company had filed over 1,800 documents worldwide, including 204 in the EU and 133 in Canada, and held 201 granted patents, with 33 pending applications and 102 drug master files submitted.
Manufacturing Capabilities
Emcure Pharmaceuticals has 13 manufacturing facilities in India, capable of producing various pharmaceutical and biopharmaceutical products, including pills, liquids, injectables, and complex ingredients like chiral molecules, iron molecules, and cytotoxic substances.
Marketing and Distribution
As of September 30, 2023, Emcure’s marketing and distribution network in India was supported by over 5,000 field personnel interacting with healthcare providers. The distribution network included over 5,000 stockists, served by 37 carry-and-forward agents.
Emcure Pharmaceuticals Limited IPO Competitive Strength
- Well-placed to Leverage our Position in the Domestic Market
- Demonstrated Capabilities of Building Brands
- Large, Diversified and Fast-Growing Product Portfolio in International Markets
- Strong R&D Capabilities Driving Differentiated Portfolio of Products
- Extensive and Diversified Manufacturing Capacity
- Highly Qualified, Experienced and Entrepreneurial Management Team and Board
Emcure Pharma IPO Financials Performance ( Results )
Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)
All Amount in ₹ Crores
| Period Ended | Total Assets | Total Revenue | PAT | Net Worth | Reserves | Borrowing |
| 31-Mar-22 | 6,063.47 | 5,918.86 | 702.56 | 1,987.55 | 1,791.03 | 2,102.19 |
| 31-Mar-23 | 6,672.53 | 6,031.72 | 561.85 | 2,501.13 | 2,293.77 | 2,202.42 |
| 31-Mar-24 | 7,806.16 | 6,715.24 | 527.58 | 2,952.28 | 2,722.40 | 2,091.94 |
Objective of Emcure Pharma IPO Issue
- Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by the company; and
- General corporate purposes
Emcure Pharma IPO Basic Details
| IPO Date | July 3, 2024 to July 5, 2024 |
| Listing Date | Wednesday, July 10, 2024 |
| Face Value | ₹10 per share |
| Price | ₹960 to ₹1008 per share |
| Lot Size | 14 shares |
| Issue Size | 9,365,346 shares of ₹10 (aggregating up to ₹1,952.03 Cr) |
| Fresh Issue | 7,936,507 shares of ₹10 (aggregating up to ₹800.00 Cr) |
| Offer for Sale | 11,428,839 shares of ₹10 (aggregating up to ₹1,152.03 Cr) |
| Issue Type | Book Built Issue IPO |
| Employee Discount | Rs 90 per share |
| Listing At | NSE, BSE |
| Share holding pre issue | 180,852,116 |
| Share holding post issue | 188,788,623 |
| Company Promoters | Satish Mehta and Sunil Mehta |
Emcure IPO Reservation
| QIB Shares Offered | 50% of the Net Issue |
| NII (HNI) Shares Offered | 15% of the Net Issue |
| Retail Shares Offered | 35% of the Net Issue |
Emcure Pharmaceuticals IPO Timetable
Emcure Pharmaceuticals IPO will open on July 3, 2024 and close on July 5, 2024. You can join Emcure Pharmaceuticals IPO at 10.00 A.M. to 5.00 p.m. Upto which mandate can be applied.
| Event | Date |
| Opening Date | 3 July 2024 (Wednesday) |
| Closing Date | 5 July 2024 (Friday) |
| Basis of Allotment | 8 July 2024 (Monday) |
| Initiation of Refunds | 9 July 2024 (Tuesday) |
| Credit of Shares to Demat | 9 July 2024 (Tuesday) |
| Listing Date | 10 July 2024 (Wednesday) |
| Deadline for UPI mandate confirmation | 5 PM on 5 July 2024 |
Emcure IPO Lot Size
For retail investors in Emcure IPO, 14 shares will come in 1 lot or the minimum investment will be ₹14,112. Retail-individual investors can apply for up to 14 lots or the maximum investment will be ₹197,568.
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 14 | ₹14,112 |
| Retail (Max) | 14 | 196 | ₹197,568 |
| S-HNI (Min) | 15 | 210 | ₹211,680 |
| S-HNI (Max) | 70 | 980 | ₹987,840 |
| B-HNI (Min) | 71 | 994 | ₹1,001,952 |
Emcure IPO Promoter Holding
The company’s promoters include Satish Mehta and Sunil Mehta.
| Pre Issue Share Holding | 98.90% |
| Post Issue Share Holding |
Emcure Pharmaceuticals Ltd IPO Key Performance Indicator ( Valuation )
In the table given below, all the figures have been told according to the latest financial year.
| KPI | Values |
| Market Cap (₹ Cr.) | 19029.89 |
| Earning Per Share (EPS) | ₹27.54 per Equity Share |
| Net Asset Value (NAV) | ₹163.22 per Equity Share |
| P/E Ratio (P/E) (x) | 34.55 |
| Post P/E Ratio (P/E) (x) | 36.07 |
| Return on Net Worth (RoNW) (%) | 16.87 |
| Return on equity (ROE) (%) | 16.90 |
| Return on Capital Employed (ROCE) (%) | 19.37 |
| Debt/Equity Ratio | 0.67 |
| Price/Book Value Ratio | 6.18 |
Emcure Pharma IPO GMP Live Update, Kostak Rate day by day
| Date | GMP | Kostak | Subject to |
| Today | ₹290 | – | – |
| 1 July 2024 | ₹290 | – | – |
Emcure IPO Detail Video:
Emcure Pharmaceuticals IPO Subscription Status (Bidding Detail)
The Emcure Pharmaceuticals IPO on July 5, 2024 at 7:02:00 PM was subscribed 67.87 times, with the retail category being subscribed 7.36 times, the NII (Non-Institutional Investor) category being subscribed 49.32 times, QIB (Qualified-Institutional Buyers) category being subscribed 191.24 times and the Employee category being subscribed 8.81 times.
| Category | Subscription |
| QIB | 191.24x |
| NII | 49.32x |
| Retail | 7.36x |
| Employee | 8.81x |
| Total | 67.87x |
Emcure Pharmaceuticals IPO Prospectus
| Emcure Pharmaceuticals IPO DRHP | Download |
| Emcure Pharmaceuticals IPO RHP | Download |
| Emcure Pharma IPO addendum to DRHP | Download |
| Emcure Pharmaceuticals IPO Anchor Investors Details PDF | Download |
Emcure IPO Rating
| Our Rating | 3.0/5.0 |
Emcure Pharma Company Contact Information
Emcure Pharmaceuticals Limited
Registered and Corporate Office: Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Pune 411 057, Maharashtra, India
Contact Person: Chetan Rajendra Sharma, Company Secretary and Compliance Officer
Tel: +91 20 3507 0033, +91 20 3507 0000
E-mail: investors@emcure.com
Website: www.emcure.com
Corporate Identity Number: U24231PN1981PLC024251
Our Promoters: Satish Ramanlal Mehta, Sunil Rajanikant Mehta, Namita Vikas Thapar and Samit Satish Mehta
Emcure Pharma IPO Registrar
Link Intime India Private Limited
Registered and Corporate Office: C-101, 1st Floor, 247 Park Lal Bahadur Shastri Marg, Vikhroli (West), Mumbai 400 083, Maharashtra, India
Tel: + 91 810 811 4949
E-mail: emcure.ipo@linkintime.co.in
Website: www.linkintime.co.in
Investor grievance e-mail: emcure.ipo@linkintime.co.in
Contact Person: Shanti Gopalkrishnan
SEBI Registration No.: INR000004058
Emcure Pharma IPO Lead Manager
Kotak Mahindra Capital Company Limited
Registered and Corporate Office: 1st Floor, C-27 BKC Plot No. 27, ‘G’ Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051, Maharashtra, India
Tel: + 91 22 4336 0000
E-mail: emcure.ipo@kotak.com
Website: https://investmentbank.kotak.com
Investor grievance e-mail: kmccredressal@kotak.com
Contact Person: Ganesh Rane
SEBI Registration No.: INM000008704
Axis Capital Limited
Registered and Corporate Office: 1st Floor, Axis House C-2 Wadia International Centre Pandurang Budhkar Marg, Worli Mumbai 400 025, Maharashtra, India
Tel: +91 22 4325 2183
E-mail: emcure.ipo@axiscap.in
Website: www.axiscapital.co.in
Investor grievance e-mail: complaints@axiscap.in
Contact Person: Sagar Jatakiya
SEBI Registration No.: INM000012029
Jefferies India Private Limited
Registered and Corporate Office: 16th Floor, Express Towers, Nariman Point, Mumbai 400 021, Maharashtra, India
Tel: +91 22 4356 6000
E-mail: Emcure.IPO@jefferies.com
Website: www.jefferies.com
Investor grievance e-mail: jipl.grievance@jefferies.com
Contact Person: Suhani Bhareja
SEBI Registration No.: INM000011443
J.P. Morgan India Private Limited
Registered and Corporate Office: J.P. Morgan Tower, Off CST Road, Kalina Santacruz East, Mumbai 400 098, Maharashtra, India
Tel: + 91 22 6157 3000
E-mail: EMCURE_IPO@jpmorgan.com
Website: www.jpmipl.com
Investor grievance e-mail: investorsmb.jpmipl@jpmorgan.com
Contact Person: Aanchal Mittal/ Saarthak Soni
SEBI Registration No.: INM000002970
Emcure Pharma IPO FAQs
What is the lot size of Emcure Pharma IPO?
The total size of Emcure Pharma IPO is ₹1,952.03 crores out of which ₹800.00 crores is fresh issue and ₹1,152.03 crores is offer for sale (OFS).
When will Emcure Pharma IPO start?
Emcure Pharma IPO will open from 3 July 2024 and IPO will close on 5 July 2024.
What is the open date of Emcure Pharma IPO?
Emcure Pharma IPO will open date from 3 July 2024.
What is the last date ( close date ) of Emcure Pharma IPO?
Emcure Pharma IPO will close from 5 July 2024.
What is the price band of Emcure Pharma IPO?
Emcure Pharma IPO price band is ₹960 to ₹1008. ( Upper Price Band: ₹1008, Lower Price Band: ₹960 )
What is the minimum amount required to apply for Emcure Pharma IPO?
The minimum investment for retailers to apply for Emcure Pharma IPO is ₹14,112 and the maximum investment is ₹197,568.
What is going on gray market premium of Emcure Pharma IPO?
View gray market premium of Emcure Pharma IPO by Clicking Here
How much is the GMP of Emcure Pharma IPO?
Watch Emcure Pharma IPO GMP Today: Click Here
What is the allotment date of Emcure Pharma IPO?
The allotment date of Emcure Pharma IPO is 8 July 2024.
How to check allotment status in Emcure Pharma IPO?
To check the allotment status of Emcure Pharma IPO, first of all go to the registrar website by clicking here, select your bad Emcure Pharma IPO name or enter your bad application number, PAN number or client ID and click on submit. ( Video Link )
What is the listing date of Emcure Pharma IPO?
The listing date of Emcure Pharma IPO is 10 July 2024.
How much will be the listing gain in Emcure Pharma IPO?
View listing gain of Emcure Pharma IPO by Clicking Here
How much time Emcure Pharma IPO is subscribed?
Total 67.87 times subscribed in Emcure Pharma IPO out of which 7.36 times subscription was done in retail quota, 49.32 times subscription in NII quota and 191.24 times subscription in QIB quota.
How to apply for Emcure Pharma IPO from Upstox?
Click Here to see how to apply for Emcure Pharma IPO from Upstox. (step by step)
How to apply for Emcure Pharma IPO from Zerodha?
Click Here to see how to apply for Emcure Pharma IPO from Zerodha. (step by step)
How to apply for Emcure Pharma IPO from Angle One?
Click Here to see how to apply for Emcure Pharma IPO from Angle One. (step by step)
